Activity: Industry, Government and Philanthropy Engagement and Partnerships › Membership of an advisory panel/policy group/ board
Invited member of Post-Market Review committee within the Pharmaceutical Benefits Division of the Department of Health charged to assess the indications for the use of biologics in the treatment of severe chronic plaque psoriasis. Prepared report to influence criteria for the use of these medications, thus changing the access to these medications.
13 Feb 2017 → 15 Mar 2018
Department of Health (Australia), Australia, Australian Capital Territory